Loading clinical trials...
Loading clinical trials...
A Multicenter, Open-Label, Ascending Multiple-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age With Selected Serious Infections
Conditions
Interventions
Tygacil
Locations
36
United States
Long Beach, California, United States
Oakland, California, United States
Orange, California, United States
San Diego, California, United States
Tampa, Florida, United States
Louisville, Kentucky, United States
Start Date
December 1, 2007
Primary Completion Date
September 1, 2009
Completion Date
September 1, 2009
Last Updated
October 24, 2012
NCT04263792
NCT06135350
NCT06322277
NCT06319235
NCT05824988
NCT05914467
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions